Infection with Helicobacter pylori is one of the strongest risk factors for development of gastric cancer. Although these bacteria infect approximately half of the world's population, only a small fraction of infected individuals develops gastric malignancies. Interactions between host and bacterial virulence factors are complex and interrelated, making it difficult to elucidate specific processes associated with H. pylori-induced tumorigenesis. In this study, we found that H. pylori inhibits p14ARF tumor suppressor by inducing its degradation. This effect was found to be strain-specific. Downregulation of p14ARF induced by H. pylori leads to inhibition of autophagy in a p53-independent manner in infected cells. We identified TRIP12 protein as E3 ubiquitin ligase that is upregulated by H. pylori, inducing ubiquitination and subsequent degradation of p14ARF protein. Using isogenic H. pylori mutants, we found that induction of TRIP12 is mediated by bacterial virulence factor CagA. Increased expression of TRIP12 protein was found in infected gastric epithelial cells in vitro and human gastric mucosa of H. pylori-infected individuals. In conclusion, our data demonstrate a new mechanism of ARF inhibition that may affect host-bacteria interactions and facilitate tumorigenic transformation in the stomach.
Introduction
Helicobacter pylori (H. pylori) is one of the most common human pathogens. Infection with this Gram-negative pathogen typically causes asymptomatic gastritis, but some infected individuals may develop MALT lymphoma or gastric adenocarcinoma. Gastric tumor remains a common cause of cancer-related death in the World, and H. pylori is recognized as the strongest contributing factor to malignancies that arise within the stomach. The risk of cancer development is determined by complex interactions between bacterial virulence and host factors. H. pylori strains show extremely high genetic diversity which accounts, at least in part, for their different tumorigenic potential [1] . One of the important genetic determinants of H. pylori virulence is the cag pathogenicity island (cag PAI). CagA (cytotoxin-associated gene A) is a product of the cag PAI region that is injected through the bacterial type IV secretion system into the host cells [2] . The presence of CagA is associated with an increased risk of gastric tumor [3, 4] .
ARF tumor suppressor is a product of the CDKN2A locus. In humans, this protein is designated as p14ARF and in mice as p19ARF [5] . The CDKN2A gene is located on chromosome 9p21, a region frequently deleted in primary gastric cancer. In addition, p14ARF gene expression was found to be inactivated by hypermethylation in more than 30% of gastric cancers [6, 7] . As a pivotal tumor suppressor, p14ARF plays critical role in oncogenic stress response (OSR), which comprises a complex network of cellular responses to oncogene activation caused by different stimuli. In part, p14ARF exerts its function as a main positive regulator of the p53 tumor suppressor, acting through interaction with HDM2 E3 ubiquitin ligase, which is responsible for degradation of p53 [8] . We have recently shown that p14ARF has crucial role in the regulation of p53 in H. pylori-infected gastric cells [9] . p14ARF was also shown to have p53-independent tumor suppressor functions [10] .
It has been reported that p14ARF plays a role in the regulation of autophagy in different cell types [11, 12] .
Autophagy is a complex and dynamic process through which eukaryotic cells degrade various cell components by engulfing them into double-membrane compartments termed autophagosomes, which are, in a later phase of the autophagic process, fused with lysosomes into autolysosomes inducing degradation of cellular components, reviewed in ref. [13] . Role of autophagy in tumorigenesis is multifaceted, as it may play both tumor suppressive and Fig. 1 Expression of p14ARF in H. pylori-infected human gastric cells is regulated in a strain-specific manner. a Left panel: SNU1 cells were co-cultured with H. pylori strain 7.13 or B128 for 6 h or left untreated (-). Western blotting was used for expression analyses of p14ARF protein. Right panel: the same as a, but AGS cells were analyzed. Protein expression of ARF was quantitated by densitometry. Data are shown as mean ± SEM (n = 3). b qRT-PCR analysis of p14ARF mRNA in H. pylori-infected cells. SNU1 cells were co-cultured with H. pylori strain 7.13 or B128 and analyzed at 2 and 6 h after infection. Relative p14ARF levels were normalized to HPRT1 mRNA expression. Data are shown as mean ± SEM (n = 2). c The effect of proteasomal and autophagic inhibitors was investigated in SNU1 cells cocultured with H. pylori strain 7.13. Expression of p14ARF protein was analyzed by western blotting. ARF protein was quantitated by densitometry. Data are shown as mean ± SEM (n = 3) tumor-promoting roles, depending on specific circumstances and the tumorigenic state.
In this paper, we investigated the mechanism of regulation of p14ARF protein by H. pylori.
Results

Expression of p14ARF is regulated by H. pylori in a strain-specific manner
We started our studies of p14ARF regulation with coculturing gastric epithelial cells with H. pylori. SNU1 was our cell line of choice because unlike most other gastric cell lines, SNU1 expresses p14ARF and wild-type p53 proteins [9] . We also took advantage of previously characterized H.
pylori clinical isolate B128 and its oncogenic derivative 7.13 [14] . The latter strain strongly activates cellular oncogenes resulting in induction of premalignant and malignant gastric lesions in different rodent models [14, 15] . SNU1 cells were co-cultured with either H. pylori strain 7.13 or B128 for 6 h or left untreated (control), and then expression of ARF protein was analyzed by western blotting. We found that levels of ARF were decreased in cells cocultured with oncogenic strain 7.13, while infection with strain B128 resulted in a slight increase of ARF protein ( Fig. 1a , left panel). In another gastric cell line, AGS, which expresses low but detectable levels of ARF, the effect of H. pylori strains 7.13 and B128 was similar to that found in SNU1 cells ( Fig. 1a, right panel) . These findings suggest that H. pylori affects protein levels of ARF in a strain-specific manner ( Fig. 1a ), which is consistent with previous findings [9] . To determine how H. pylori alters protein levels of ARF, we first analyzed mRNA levels of ARF in SNU1 cells cocultured with strain 7.13 or B128 using qRT-PCR ( Fig. 1b ). No significant differences were found between infected and control uninfected cells, suggesting that post-transcriptional mechanisms are likely involved in the regulation of ARF protein in H. pylori-infected cells. However, given a slight decrease in ARF mRNA levels in cells infected with H. pylori strain 7.13, inhibition of transcription cannot be completely excluded.
Next, we asked whether proteasomal and autophagic degradation systems regulate protein levels of ARF in infected cells. To explore these possibilities, we employed proteasomal inhibitor MG132 and bafilomycin A. The latter inhibits lysosomal acidification necessary for autophagosome maturation [16] . SNU1 cells were co-cultured with H. pylori strain 7.13 for 3 h and then treated with bafilomycin A or MG132 for an additional 4 h at final concentrations 100 nM and 20 µM, respectively. To exclude possible indirect effects of inhibitors on the bacteria, they were eliminated with kanamycin treatment. We found that MG132, but not bafilomycin A, inhibits downregulation of p14ARF protein caused by H. pylori strain 7.13, implicating the proteasomal degradation system in the regulation of ARF protein in infected cells ( Fig. 1c ).
H. pylori infection induces ubiquitination and degradation of p14ARF
It has been previously reported that p14ARF protein undergoes N-terminal polyubiquitination that regulates ARF degradation [17] . To explore whether H. pylori strains affect p14ARF polyubiquitination, we used an approach similar to that previosly described [17] . AGS cells, which express low levels of ARF, were co-transfected with plasmids expressing human ARF and ubiquitin, co-cultured with H. pylori strain 7.13 or B128 for 90 min and treated with proteasomal inhibitor MG132 for an additional 7 h. Infected and control cells were collected and lysed. p14ARF was then immunoprecipitated from cellular lysates with ARF-specific antibody and analyzed for polyubiquitination by western blotting. Our experiments found that tumorigenic strain 7.13 induces significantly higher levels of ARF polyubiquitination than that of B128 ( Fig. 2a , compare lanes 4 and 5).
To investigate whether H. pylori-induced polyubiquitination affects stability of ARF protein, we employed the cycloheximide chase assay. Similar to the aforementioned experiment, AGS cells, which ectopically express ARF, were co-cultured with H. pylori strain 7.13 or B128. Six-hour post infection, cycloheximide (de novo protein synthesis inhibitor) was added to cell culture media at a final concentration 150 µM. Cells were then collected at 0, 2, 4, 6, and 12 h after treatment and analyzed by western blotting (Fig. 2b ). We found that stability of ARF protein was significantly lower in gastric cells infected with strain 7.13 (half-life is~2 h) than with B128 (half-life is longer than 12 h). Combined, these experiments show that infection with the oncogenic H. pylori strain 7.13 leads to increased ubiquitination and subsequent proteasomal degradation of ARF protein.
Downregulation of p14ARF leads to inhibition of autophagy in gastric cells
Our data raised an important question about a potential biological impact of degradation of p14ARF protein by H. pylori. One of the cellular processes that plays a critical role in host-microbe interactions and gastric tumorigenesis is autophagy. It has been previously reported that p14ARF is involved in regulation of autophagy [11, 12] . Based on these facts, we explored how ARF alterations induced by H. pylori affect autophagy.
We first assessed autophagy in infected cells. SNU1 cells were infected with H. pylori strain 7.13 or B128 and analyzed for protein expression of ARF and commonly-used autophagic markers, LC3B-II and Beclin 1. Cells cocultured with oncogenic strain 7.13 showed not only a decreased expression of ARF protein but also decreased levels of LC3B-II and Beclin 1 proteins, pointing to a lower level of autophagy in those cells ( Fig. 3a) . In contrast, infection with strain B128 led to significantly higher levels of LC3B-II and Beclin 1 proteins. To explore this phenomenon further, SNU1 cells, in which p14ARF protein was downregulated with specific siRNA, were co-cultured with H. pylori strain 7.13 or B128 or left uninfected for the indicated time (Fig. 3b ). Analyzing LC3B-II and Beclin 1, we found that downregulation of ARF even further decreases autophagy in infected cells. Decrease in ARF levels also affected basal autophagy in control uninfected cells. pylori-infected cells leads to inhibition of autophagy. a SNU1 cells were co-cultured with 7.13 or B128 strain for 6 h or left uninfected (-), and p14ARF, LC3B, and Beclin 1 proteins were analyzed by western blotting. Proteins were quantitated by densitometry. Data are shown as mean ± SEM (n = 3). b Expression of p14ARF, LC3B, and Beclin 1 proteins was analyzed in SNU1 cells, in which ARF was downregulated with specific siRNA (ARF) or scrambled control siRNA (CTRL) for 48 h. Cells were then co-cultured with strain 7.13 or B128 for the indicated time (+) or left uninfected (-). Protein were quantitated by densitometry. Data are shown as mean ± SEM (n = 3). c Autophagic flux was inhibited in SNU1 cells in which ARF was downregulated with specific siRNA (ARF) or scrambled control siRNA (CTRL) for 48 h. Cells were cocultured with strain 7.13 for 2 h and treated with pepstatin A and E-64d Since autophagy is a multistep and dynamic process, we next investigated autophagic flux in ARF-deficient cells using pepstatin A and E-64d (INH), which interfere with autolysosomal digestion of LC3B-II. Consistent with the experiments shown above, downregulation of p14ARF led to inhibition of autophagic flux in infected cells (Fig. 3c ), as measured by LC3B-II.
To visualize the autophagic flow, we used a retrovirus, which, following transduction, expresses LC3B conjugated to fluorescent proteins mCherry and GFP. This approach allowed us to track progression of autophagy in situ (see "Materials and Methods" section). SNU1 cells, which retrovirally express mCherry-EGFP-LC3B, were transfected with ARF or control siRNAs. These cells were then cocultured with H. pylori strain 7.13 for 4 h or left uninfected and analyzed for the autophagic puncta formation (Fig. 3d ). We found that ARF downregulation markedly decreases the abundance of acidic autolysosomes (detected as red-only puncta in mCherry-EGFP-LC3B-expressing cells), providing additional proof that inhibition of ARF by H. pylori leads to inhibition of autophagic flux.
To further confirm our findings, we overexpressed ARF in AGS cells, which are characterized by low levels of endogenous ARF protein. Eighteen hour following transfection, AGS cells were co-cultured with H. pylori strain 7.13 and lysates were analyzed for LC3B protein at the indicated time points (Fig. 3e ). We found that ectopic overexpression of ARF increased levels of LC3B-II. A similar increase was also seen for Beclin 1 protein, showing that ARF induces autophagy in AGS cells.
Since it has been shown that ARF affects stability and activity of p53 protein, we next asked whether the effect of ARF on autophagy, found in our experiments, is mediated by p53. To explore this possibility, we took advantage of isogenic cell lines HCT116 p53 +/+ , which expresses wildtype p53 and ARF, and its isogenic p53-null derivative HCT116 p53 −/− . Using specific siRNA, ARF protein was downregulated in these cells, which were then co-cultured with H. pylori strain 7.13 (MOI 200) and analyzed for autophagy at the indicated time points (Fig. 4 ). We found that downregulation of ARF leads to inhibition of autophagy not only in cells expressing wild-type p53, but also in p53-null cells, demonstrating that, at least in part, the effect of ARF on autophagy is independent of p53 in infected cells.
Taken together, out data revealed that a tumorigenic strain of H. pylori can induce degradation of ARF protein resulting in inhibition of autophagy.
TRIP12 E3 ubiquitin ligase is induced in H. pyloriinfected gastric cells
Another important question raised by our studies is how H. pylori regulates ARF protein. Because a number of E3 ubiquitin ligases have been reported to regulate ARF protein, such as TRIP12/ULF (thyroid hormone receptor interacting protein 12), SIVA1, and MKRN1 (Makorin ring finger protein 1) [18] [19] [20] , we explored expression of these proteins in SNU1 cells co-cultured with strain 7.13 or B128. We found that both strains upregulate TRIP12 protein, while other protein E3 ubiquitin ligases did not show increases. Notably, strain 7.13 was a significantly stronger inducer of TRIP12 than was B128 (Fig. 5a ). Similar effects were seen in the other tested cell lines, AGS and mGEC (Supplemental Figures 1A and 1B) To investigate the contribution of TRIP12 to the regulation of ARF in infected cells, its expression was downregulated with TRIP12-specific siRNA in SNU1 cells and then ARF protein was analyzed after co-culturing cells with strain 7.13 or B128. We found that protein levels of p14ARF were significantly increased as a result of TRIP12 downregulation. Moreover, downregulation of TRIP12 had a stronger effect in infected cells (Fig. 5b) .
Finally, the expression of TRIP12 was analyzed by immunohistochemistry in gastric mucosa from 33 H. pyloriinfected and 5 uninfected human individuals who underwent GI tract endoscopy. H. pylori-infected patients were divided into two groups based on their diagnosis (nonatrophic gastritis or intestinal metaplasia). We found that expression of TRIP12 was significantly higher in both groups of infected patients compared with uninfected ( Fig.  5c) , showing that H. pylori also induces TRIP12 in vivo.
Role of CagA and other H. pylori virulence factors
Genes within the cag PAI region have been shown to significantly affect host-microbe interaction [2] . To assess the role of CagA in regulation of ARF, isogenic cagA− and cagE− null-mutants were generated, and their ability to affect ARF protein was examined. SNU1 cells were cocultured with H. pylori strain 7.13 or its isogenic cagA− and cagE− mutants. ARF proteins were then analyzed by western blotting (Fig. 6a ). We found that deletion of cagA inhibits degradation of ARF by H. pylori. Notably, the cagE − mutant, which is deficient in delivery of CagA protein into the host cells [21] , does not affect ARF regulation. Similarly, the ability of H. pylori to upregulate TRIP12 was significantly compromised by loss of either cagA or cagE (Fig. 6a) . To further investigate the role of CagA, SNU1 and AGS gastric cells were transfected with cagA-expressing plasmid (Fig. 6b, c) . Transfection of CagA led to an increased expression of TRIP12 protein and downregulation of ARF. When CagA was co-transfected with TRIP12 siRNA, it inhibited downregulation of ARF and restored its protein level (Fig. 6c) . These results show that CagA, a component of the cag PAI, negatively regulates ARF through induction of TRIP12.
Discussion
We report that H. pylori actively regulates the p14ARF tumor suppressor. As a model for infection, we used two previously characterized H. pylori strains B128 and 7.13 with different oncogenic potential [14] . Strain B128 is a human clinical isolate, which failed to induce tumors in rodents. In contrast, its derivate strain 7.13, which was generated by in vivo adaptation in Mongolian gerbils, induces severe gastritis, pre-neoplastic and neoplastic lesions in rodent animal models. Moreover, tumorigenic H. pylori strain 7.13 was characterized by the ability to strongly induce WNT/β-catenin, RAS/Erk and PI3K/AKT signaling pathways, which are often aberrantly activated during gastric tumorigenesis [14] . In our experiments, strain 7.13 caused strong induction of TRIP12, while B128 did not produce similar effects. This induction was accompanied by strong ubiquitination and degradation of ARF protein by strain 7.13. The observed differences between the two strains in the regulation of ARF tumor suppressor provide one more example of modulation of the host signaling pathways by H. pylori that may contribute to gastric tumorigenesis.
As a pivotal tumor suppressor, ARF has important functions in the oncogenic stress response (OSR), an intrinsic network of cellular processes directed toward prevention of tumorigenic transformation. Although H. pylori was shown to activate many oncogenic pathways [14, 22] , mechanisms of OSR regulation in infected cells remain unclear. Disruption of ARF signaling by inducing its degradation shows one potential mechanism by which H. pylori can circumvent the host OSR.
We analyzed the effect of p14ARF downregulation induced by H. pylori on autophagy, a critical process for maintaining cellular homeostasis. Our findings are consistent with previous reports on autophagic functions of ARF [11, 12, 23] . However, this effect was often attributed to smARF, a short form of ARF protein, which localizes primarily to the mitochondria [24] . Our results are consistent with previous reports, in which induction of autophagy were attributed, at least in certain conditions, to fulllength nucleolar p14ARF [11, 12] . The contribution of smARF, however, cannot be excluded.
Since ARF controls p53 tumor suppressor by multiple mechanisms, and p53 is known to regulate autophagy [25] , we investigated how degradation of p14ARF affects autophagy in infected p53 null cells. In these conditions, p14ARF affects autophagy independently of p53, which may work parallel to ARF to regulate autophagy in p53expressing cells.
We found that induction of TRIP12 E3 ubiquitin ligase by H. pylori contributes to degradation of p14ARF in H. pylori-infected cells. When induction of TRIP12 protein was compared between strains, tumorigenic H. pylori strain 7.13 was found to be a much stronger inducer of TRIP12 than was B128. Strain 7.13 was also a stronger inducer of ubiquitination of ARF protein, resulting in its faster degradation in the proteasomes. Another interesting finding is that induction of TRIP12 is mediated by bacterial virulence factor CagA, which is delivered into gastric epithelial cells upon bacterial attachment. Isogenic cagA− and cagE− mutants, which do not deliver CagA, were found to have significantly weaker ability to upregulate TRIP12 than the parental wild-type strain. Notably, ectopic overexpression of CagA protein is sufficient to induce TRIP12 and ARF downregulation. Additional studies are needed to further investigate the mechanism of TRIP12 induction by CagA. Our analyses of SIVA1 and MKRN1 E3 ubiquitin ligases, which are known to regulate ARF, did not reveal their upregulation in H. pylori-infected cells. However we cannot exclude their involvement in p14ARF regulation in H. pylori-infected cells.
The important role of TRIP12 is further emphasized by our findings that TRIP12 protein is upregulated in infected gastric mucosa. This finding is especially interesting, given that upregulation of TRIP12 has been reported in different human cancers [26, 27] .
In conclusion, we found that H. pylori bacterial pathogen inhibits activity of p14ARF protein causing inhibition of autophagy in infected cells. This may, in turn, affect host-bacteria interactions. ARF inhibition may also facilitate tumorigenic transformation, as this protein plays an essential tumor suppressor role in the stomach. [14] or its isogenic cagA− or cagE− mutants for 2 h, p14ARF protein was then assessed by western blotting. b SNU1 or AGS cells were transfected with CagA-expressing plasmid (+) or empty vector (−) for 24 h. TRIP12 protein was analyzed in AGS cells (upper panel). Given that SNU1 cells express higher levels of ARF protein than AGS, ARF was assessed in SNU1 cells (lower panel). c AGS cells transfected with ARF and GFP plasmids were co-transfected with either empty vector or CagAexpressing plasmid and siRNA against TRIP12 as indicated in the panel. TRIP12 and p14ARF proteins were analyzed using western blotting. β-actin and GFP were used for normalization of protein loading and transfection efficiency, respectively
Materials and methods
Cell culture media and cell lines F12 medium, containing 10% FBS (Thermo Fisher, Waltham, MA), was used for culturing human gastric cancer cell lines AGS and SNU1. These cell lines were purchased from ATCC (Manassas, VA) and authenticated by the supplier. The ATCC uses PCR-based assays, karyotyping, and other approaches to confirm the identity of cell lines. Dulbecco's modified Eagle's medium (Thermo Fisher) with 10% FBS was used for culturing colon cancer cell lines HCT116 p53 +/+ and HCT116 p53 −/− (kindly provided by Dr. Bert Vogelstein), as well as Phoenix Amphotropic cells. mGECs, conditionally immortalized murine gastric epithelial cells, were generated from transgenic mice expressing the temperature-sensitive mutant of SV40 large T antigen and cultured as described previously [28] .
Cells were transfected with Lipofectamine 2000 (Thermo Fisher) or Fugene 6 (Promega), according to the manufacturer's recommendations.
Co-culture of epithelial cells with H. pylori H. pylori strains B128, 7.13, isogenic 7.13 cagA− and 7.13 cagE− null-mutants were described previously [14, 15, 29] . Bacteria were grown in Brucella broth containing 10% FBS, harvested by centrifugation and used for infection at bacteria to cell ratio 100:1 (MOI 100) unless mentioned otherwise.
Reagents
Plasmids expressing HA-ubiquitin and CagA were described previously [30, 31] . pBABE-puro mCherry-EGFP-LC3B and pcDNA3-ARF constructs were purchased from Addgene (Cambridge, MA) [32] .
Sequences 5′-CAUGGUGCGCAGGUUCUUGGUGAC C-3′ and 5′-CCAGGAGCAACAACUGAAAUCUGCA-3′ were used to generate siRNAs against p14ARF and TRIP12, respectively. All siRNAs were synthesized by Integrated DNA Technologies (Coralville, Iowa). Control siRNA was purchased from Ambion (Grand Island, NY).
Rabbit polyclonal anti-TRIP12 (A301-814A) and anti-MKRN1 (A300-990A) antibodies (Ab) were from Bethyl Laboratories (Montgomery, TX); rabbit polyclonal SIVA1 Ab was from Abnova (Walnut, CA); rabbit monoclonal anti-p14ARF (clone EPR17878, ab185620) Ab was from Abcam (Cambridge, MA); mouse monoclonal anti-β-Actin (clone AC-74) Ab was from Sigma (St. Louis, MO); mouse monoclonal anti-GFP Ab was from Vanderbilt Monoclonal Antibody Core (Nashville, TN); rabbit polyclonal anti-Beclin-1 (#3738) and anti-LC3B (#2775) Ab were from Cell Signaling (Danvers, MA). The following secondary antibodies were used: HRP-conjugated anti-mouse IgG from Promega and HRP-conjugated anti-rabbit IgG from Cell Signaling.
Proteasomal inhibitor MG132 was purchased from EMD Millipore (Burlington, MA). Cycloheximide, bafilomycin A, pepstatin A, and E-64d were all from Sigma.
Protein stability and ubiquitination assays
AGS cells were transfected with p14ARF-expressing plasmid for 18 h and co-cultured with H. pylori strain 7.13 or B128 for an additional 6 h. Cycloheximide was added to suppress de novo protein synthesis at a final concentration 150 µM. Cells were analyzed at the indicated time intervals.
To analyze ARF ubiquitination, AGS cells were cotransfected with plasmids expressing p14ARF and ubiquitin for 24 h, co-cultured with H. pylori strain 7.13 or B128 for 90 min and then treated with MG132 (20 µM) for an additional 7 h. Cells were collected and lysed as described previously [17] . Cell lysates were sonicated and centrifuged twice at 4°C for 20 min. p14ARF protein was immunoprecipitated with ARF antibody using Protein-A agarose beads and analyzed by western blotting using p14ARF antibody.
Tissue specimens (patient samples) and immunohistochemistry
Endoscopic gastric tissue specimens were collected from 33 H. pylori-infected and 5 uninfected individuals in Columbia as previously described [33] . All participants provided informed consent; personal identifiers were removed prior to receiving specimens. The protocol was approved by the Institutional Review Board at Vanderbilt University and the Committees on Ethics of Universidad del Valle and Hospital Departmental in Nariño, Colombia.
Expression of TRIP12 protein was analyzed by immunohistochemistry using anti-TRIP12 antibody (A301-814A, Bethyl Laboratories) diluted 1:400. Immunohistochemical staining was evaluated for staining frequency and intensity in superficial gastric epithelium, as previously described [9] .
Puncta formation assay mCherry-EGFP-LC3B construct was used for detection of autophagic flux [32] . Briefly, SNU1 cells were transduced with a retrovirus-expressing mCherry-EGFP-LC3B and selected with 1 µg/ml puromycin. The transduced cells were transfected with siRNA against p14ARF or control siRNA using Fugene 6 reagent, plated onto 8-well chambers and co-cultured with H. pylori strain 7.13 for 4 h. Cells were fixed with 4% paraformaldehyde and analyzed using a fluorescent microscopy for puncta formation.
Quantitative RT-PCR
The RNeasy Kit from Qiagen (Valencia, CA) was used for isolation of cellular RNA. cDNA was generated using the High Capacity cDNA Reverse Transcription Kit from Applied Biosystems (Carlsbad, CA). The following primers were used: GTTTTCGTGGTTCACATCCC and ACCAG CGTGTCCAGGAAG for expression analyses of ARF mRNA and TTG GAAAGGGTGTTTATTCCTCA and TC CAGCAGGTCAGCAAAGAA for analyses of HPRT mRNA. HPRT was used as an internal control.
Statistical analysis
Wilcoxon rank-sum test was used for comparison of gastric tissue specimens. Laboratory specimens were analyzed using either Student's t-test or Mann-Whitney test, depending on the data set. Results were shown as mean ± SEM. Results were considered significant if p < 0.05 (*p < .05, **p < .01 ***p < .001, ns p > .05).
